Traditional Chinese Medicine Combined With Chemotherapy and Cetuximab or Bevacizumab for Metastatic Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

• Main Authors: Ningning Liu (Author), Chaojun Wu (Author), Ru Jia (Author), Guoxiang Cai (Author), Yan Wang (Author), Lihong Zhou (Author), Qing Ji (Author), Hua Sui (Author), Puhua Zeng (Author), Haijuan Xiao (Author), Huaimin Liu (Author), Jiege Huo (Author), Yuanyuan Feng (Author), Wanli Deng (Author), Qi Li (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundHuangci Granule is a traditional Chinese medicine for treating metastatic colorectal cancer (mCRC).ObjectiveTo evaluate the efficacy and safety of Huangci Granule combination with chemotherapy and cetuximab (CET) or bevacizumab (BV) for treating mCRC.MethodsWe performed a randomized, contr...